|Bid price||6.75||Open price||7.00|
|Ask price||7.25||Prev close||7.00|
Register now for FREE live LiDCO Group share prices, LiDCO Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get LiDCO Group Level 2 Data, indepth research tools and investor commentary for LiDCO Group (LID) and other London Stock Exchange equities.
Register now for FREE LiDCO Group share price charts
|Sector||Health Care Equipment & Services||ISIN||GB0030546849|
|Activites||LiDCO plc is a UK-based AIM-traded developer, manufacturer and leading supplier of minimally invasive, computer-based hemodynamic monitoring equipment and disposables used primarily for the management of critical care and cardiovascular risk hospital patients. Use of LiDCO's technology has been shown to significantly reduce the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London where the Company maintains a research base. The Company's manufacturing facility is in Hoxton, London and its current products are: LiDCOplus and PulseCO monitors: computer-based platforms for displaying a range of real-time, continuous hemodynamic parameters including cardiac output, oxygen delivery and fluid volume; LiDCO disposables: used in conjunction with the LiDCOplus Monitor to accurately determine cardiac output in a minimally-invasive manner.||Index||n/a|
|Latest Share Price (p)||7.00||Net Gearing (%)||0.12|
|Market Capitalisation (£m)||13.59||Gross Gearing (%)||17.81|
|Shares in issue (m)||194.17||Debt Ratio||0.00|
|P/E Ratio||-33.33||Debt-to-Equity Ratio||0.00|
|Total dividends per share (p)||0.00||Assets / Equity Ratio||1.22|
|Dividend Yield (%)||0.00||Price to book value||1.84|
|Dividend cover (x)||0.00||ROCE (%)||-7.87|
|Earning per share (p)||-0.21||EPS Growth (%)||-216.67|
|52 week high / low||8.75 / 5.50||DPS Growth (%)||n/a|
|Dec.Date||Type||Director||Pos||No. of Shares|
LiDCO has narrowed its H1 pretax loss to £353,000, from a year-earlier loss of £689,000. Revenue was £3.8m, from £3.6m. "Our performance in H1 is in line with expectations as we execute on our strategy," said CEO Matt Sassone in a statement. "We remain focused on building on our solid...
Story provided by StockMarketWire.com
RNS Number : 1615M LiDCO Group Plc 11 October 2016 11 October 201 6 LIDCO GROUP PLC ("LiDCO", "Group" or the "Company") Half-year Report Interim Results for the six months ended 31 July 201 6 LiDCO (AIM: LID), the hemodynamic...
Register now for FREE LiDCO Group company news
Lidco...the AIM listed cardiac sensor systems developer...is breaking out into new territory today....it had retraced recently on profit taking after recent rises.....its well on the way to next major break out which is being driven by the transition from development company to sales &...
Register now for FREE LiDCO Group share price discussions